Compare PD & QDEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PD | QDEL |
|---|---|---|
| Founded | 2009 | 1979 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Medical Specialities |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 989.5M |
| IPO Year | 2019 | 2022 |
| Metric | PD | QDEL |
|---|---|---|
| Price | $15.83 | $10.61 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 9 | 3 |
| Target Price | $13.14 | ★ $15.00 |
| AVG Volume (30 Days) | 1.2M | ★ 2.2M |
| Earning Date | 11-27-2026 | 11-03-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 416.95 | 45.35 |
| EPS | ★ 0.19 | N/A |
| Revenue | $492,546,000.00 | ★ $2,730,200,000.00 |
| Revenue This Year | $0.35 | N/A |
| Revenue Next Year | $2.03 | N/A |
| P/E Ratio | $83.92 | ★ N/A |
| Revenue Growth | ★ 5.36 | N/A |
| 52 Week Low | $5.70 | $9.92 |
| 52 Week High | $18.06 | $35.58 |
| Indicator | PD | QDEL |
|---|---|---|
| Relative Strength Index (RSI) | 45.97 | 38.59 |
| Support Level | $6.08 | $10.49 |
| Resistance Level | $17.81 | $18.15 |
| Average True Range (ATR) | 0.60 | 1.22 |
| MACD | -0.21 | -0.35 |
| Stochastic Oscillator | 24.91 | 9.19 |
PagerDuty Inc is a digital operations management platform that manages urgent and mission-critical work for a modern, digital business. Its PagerDuty Operations Cloud combines artificial intelligence (AI) operations (AIOps), automation, customer service operations, and incident management with a generative AI assistant to create a flexible, resilient, and scalable platform to protect revenue and improve customer experience, improve operational efficiency, and mitigate the risk of operational failures. The company generates revenue predominantly from cloud-hosted software subscription fees and term-license software subscription fees. Geographically, the company derives a majority of its revenue from the United States and the rest from International markets.
QuidelOrtho Corp is engaged in the development, manufacturing, and marketing of rapid diagnostic testing solutions. The company is engaged in immunoassay and molecular testing, clinical chemistry, and transfusion medicine, which helps clinicians and patients to make decisions across the globe. Geographically, the company has its presence in North America, EMEA, China, and Other countries. It generates the majority of its revenue from North America.